Retatrutide 30mg reference profile
Retatrutide (LY3437943) is a modified peptide designed with agonist activity at the GIP, GLP-1 and glucagon receptors. It is an investigational molecule studied in metabolic and receptor-signalling research.
Scientific nameRetatrutide
SynonymsLY3437943
ClassificationModified triple-receptor agonist peptide / research material
Research context
- GIP, GLP-1 and glucagon receptor signalling
- Multi-agonist peptide design and receptor pharmacology
- Metabolic pathway and energy-balance research models
Peer-reviewed clinical research identifies retatrutide as a single peptide with agonist activity across the GIP, GLP-1 and glucagon receptor systems. Aureon Research supplies catalogue material for laboratory research only and does not present it as an approved medicine.
Analytical and handling notes
Storage & handling
Follow the current batch documentation and the receiving laboratory's validated storage protocol.
Analytical notes
Use the current batch documentation for the supplied Retatrutide form and analytical result. Reference records may describe different salt or presentation forms.
Research-only presentationNo human or veterinary administration, dosing or consumption information is provided on this page.
Reference sources
PubMed: Retatrutide phase 2 receptor-profile studyExternal scientific referenceOpen source ↗PubChem: Retatrutide sodium-salt reference recordExternal scientific referenceOpen source ↗